Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer

University of Milano Bicocca · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breastcancermetastaticbreastcancertriplenegativebreastcancer
breast cancer, metastatic breast cancer, triple negative breast cancer, triple negative, second line, eribulin, real world, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 852144
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.